Evidence map›Paper›PMID 41785285›Full record

ArticlePloS one2026

Meningococcal carriage and transmission dynamics in college students in Louisville, Kentucky.

Forest W Arnold, Leslie Wolf Parrish, Subathra Marimuthu, Jamie Findlow, Angela Quinn, Vidyulata Salunkhe, Daniya Sheikh, Phillip Bressoud, T'shura Ali, Dawn Balcom and 11 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Forest W ArnoldDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.ORCID https://orcid.org/0000-0002-9279-2046
Leslie Wolf ParrishDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Subathra MarimuthuDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Jamie FindlowGlobal Vaccines, Medical Affairs, Pfizer Ltd, Tadworth, Surrey, United Kingdom.
Angela QuinnMedical Affairs, Pfizer Inc, Collegeville, Pennsylvania, United States of America.
Vidyulata SalunkheDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Daniya SheikhDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Phillip BressoudDepartment of Internal Medicine, Campus Health Services, University of Louisville, Louisville, Kentucky, United States of America.
T'shura AliDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.ORCID https://orcid.org/0000-0002-7655-4283
Dawn BalcomDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Mohammad AliMedical Affairs and Evidence Generation, Pfizer Inc, Collegeville, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0003-1410-388X
Ryan S DosterDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Deepti DeeptiDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Mohammad TahboubDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Fama NdiayeDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Jay LucidarmeMeningococcal Reference Unit, United Kingdom Health Security Agency, Manchester Royal Infirmary, Manchester, United Kingdom.ORCID https://orcid.org/0000-0001-5553-2512
Stephen A ClarkMeningococcal Reference Unit, United Kingdom Health Security Agency, Manchester Royal Infirmary, Manchester, United Kingdom.
Ray BorrowMeningococcal Reference Unit, United Kingdom Health Security Agency, Manchester Royal Infirmary, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-0691-6568
Paul BalmerMedical Affairs and Evidence Generation, Pfizer Inc, Collegeville, Pennsylvania, United States of America.
Steven GooteeDivision of Infectious Diseases, School of Medicine, University of Louisville, Louisville, Kentucky, United States of America.ORCID https://orcid.org/0009-0007-1355-3834
CERID study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeisseria meningitidis is a cause of meningitis and outbreaks of it among young adults, especially college students. Rates of nasopharyngeal colonization and prevalence of specific capsular groups vary with age, geography as well as time, and may be influenced by meningococcal vaccination. The objective of this study was to measure the change in colonization rate, and define which meningococcal genogroups were present, in college students over a 3-month semester.

methodsThis was a prospective, longitudinal cohort study with sequential oropharyngeal swabbing among college students at the University of Louisville (UofL) in Louisville, Kentucky from August to November 2022. Participants were ≥18 years of age and were enrolled within 48 hours of moving to campus-affiliated housing. Oropharyngeal swabs were collected at enrollment, one month and at three months. Samples were screened for N. meningitidis, and isolates were characterized using phenotypic and genotypic methods. Behavior questionnaires were obtained at each visit to identify risk factors for N. meningitidis colonization.

resultsA total of 1047 participants were seen initially, of whom 821 attended all three visits. The baseline colonization rate was 3.5% followed by 3.9% after one month and 5.7% after three months. The genogroups of recovered isolates were capsule null (48%), B (38%; of which 11% were expressing capsule) and E (12%). No genogroup ACWY isolates were recovered. A total of 36% of participants had a history of receiving at least one MenB vaccine dose and 74% had a history of receiving at least one MenACWY vaccine. Risk factors for N. meningitidis nasopharyngeal carriage included being a second-year student, living on campus for the second year, smoking/vaping, kissing and sexual contact.

conclusionsAn increase in N. meningitidis colonization over the 3-month semester was observed from 3.5% to 5.7%. The overall proportion of student carriers was significantly lower, and there were no genogroup A, C, W or Y strains isolated compared to studies conducted prior to the availability of meningococcal vaccines and the COVID-19 pandemic. However, genogroup B carriage, transmission and acquisition were almost identical to pre-COVID pandemic studies. This study reinforces the importance of periodic epidemiological monitoring of carriage as well as disease.

Indexed as

Carrier StateMeningococcal InfectionsNeisseria meningitidisStudentsAdolescentAdultFemaleHumansKentuckyLongitudinal StudiesMaleNasopharynxProspective StudiesUniversitiesYoung Adult

Identifiers

PMID41785285
PMCPMC12962471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.